• September 7, 2007

    Title VII Suit Against US Airways Moves Forward

    US Airways Inc. was unable to get an emotional distress claim tossed on Wednesday in a gender and sexual discrimination suit filed against it by a temporary office administrator who was passed over for a permanent position at the airline.

  • September 7, 2007

    Glaxo Seeks To Bar Testimony In Paxil Case

    GlaxoSmithKline has moved to strike portions of the plaintiffs' expert witness testimony in discovery for a case alleging that the antidepressant Paxil caused the plaintiff's violent behavior and suicide attempt.

  • September 5, 2007

    Battle Escalates Over Fees In Werner Bankruptcy

    A feud over compensation sought by the financial advisers of bankrupt Werner Holding Co. has taken a curious turn, with a creditor now decrying fees for work performed defending the fees.

  • September 5, 2007

    Judge Greenlights Linerboard Class Action

    Plaintiffs have sufficiently pled that manufacturers conspired to fix linerboard prices in violation of the Sherman Act, a federal judge affirmed Thursday, while limiting the plaintiffs' proposed class period.

  • September 6, 2007

    Reed Smith

    As the U.S. style of litigating product liability cases stretches to Europe, Reed Smith LLP has expanded its pool of international attorneys so that it can better handle product liability cases on both continents.

  • September 4, 2007

    Judge Kicks Multiple Claims In DRAM Antitrust Case

    A federal judge dismissed most—but not all—of the claims brought by state attorneys general against Dynamic Random Access Memory manufacturers on Friday in an ongoing multidistrict antitrust litigation over alleged price-fixing in the industry.

  • August 30, 2007

    Union Members Sue Over Election Kerfuffle

    Hinting at internal strife, nearly a dozen members of the Philadelphia Transport Workers Union have accused the administration of their local branch of deliberately trying to shut them out of the labor organization's election process.

  • August 30, 2007

    Pennsylvania Drops K-Dur Antitrust Suit

    Pennsylvania has dropped its lawsuit against health care giants Schering-Plough Corp., Upsher-Smith Laboratories Inc. and Wyeth Pharmaceuticals Inc., which accused them of striking a pact to keep the generic version of heart drug K-Dur 20 from reaching the market.

  • August 29, 2007

    Rigas Family Urges Court To Ban Deloitte's Retreat

    A lawyer for the founders of bankrupt Adelphia Communications Corp. has filed a petition to a Pennsylvania state court to block moves by auditors Deloitte & Touche LLP to withdraw their fraud case against the family.

  • August 29, 2007

    Two Plaintiffs Added In Citigroup FLSA Suit

    Putative class members in a lawsuit accusing Citigroup Inc. of improperly classifying certain employees as exempt from the overtime pay requirements of the Fair Labor Standards Act have added two new plaintiffs to the suit, which seeks relief under both federal and state law.

  • August 28, 2007

    Appeals Court Affirms Ruling in Philly Corruption Case

    A federal appeals court has upheld the convictions of two former Commerce Bank executives, a former Philadelphia city treasurer and two others in a wide-ranging 2005 case involving allegations of corruption in connection with the way companies were given city contracts in Philadelphia.

  • August 24, 2007

    Rigas Family Cries Foul Over Deloitte Trial Backdown

    The founders of bankrupt Adelphia Communications Corp. have slammed threats by accounting firm Deloitte & Touche to refile claims against the jailed executives at a later date, after it withdrew its case just weeks before the trial was set to start.

  • August 24, 2007

    Commission Backs $7.3B KeySpan Deal

    After months of back and forth, The New York State Public Service Commission has unanimously approved the $7.3 billion merger of KeySpan Corp. and British power giant National Grid PLC, removing one of the last remaining obstacles to the buyout deal.

  • August 21, 2007

    Exelon Fights ERISA Plaintiffs' Bid To Lift Stay

    Exelon Corp. has lashed out at a bid by employees who sued the electric utility for allegedly charging unreasonable 401(k) plan fees to lift a stay, arguing that the stay should remain in place in anticipation of an appellate ruling that may inform theories of liability in the ERISA class action.

  • August 22, 2007

    Corrected: Federal Law Shields Drug Giant, Court Says

    An appeals court has tossed out a potential class action against AstraZeneca alleging deceptive advertising in its marketing of blockbuster Nexium, ruling the state consumer protection claims were preempted by federal law.

  • August 20, 2007

    Attorneys Plead For New Class In Fosamax Case

    Hoping to pursue a two-pronged campaign against Merck & Co., the attorneys involved in the Fosamax product liability litigation have asked the court to certify a class of plaintiffs apart from those who claim to have suffered painful deterioration of the jaw after taking the osteoporosis medication.

  • August 17, 2007

    FedEx Faces Suit Over Bar Code Patent

    FedEx Corp. has been hit with a new lawsuit in the Eastern District of Texas that alleges the package delivery company is liable for infringing a single patent relating to bar codes.

  • August 15, 2007

    Plaintiffs Seek Certification In Pfizer Class Action

    The plaintiffs in a suit against Pfizer Inc. have sought class action certification from a federal judge in Manhattan, marking the latest development in a series of legal battles between pharmaceutical companies and workers who claim the companies improperly classified them as exempt from overtime pay.

  • August 14, 2007

    EU Warns Member States About Chinese Toothpaste

    The European Commission has asked member states to withdraw certain Chinese toothpastes from their markets, after finding that the products are counterfeit and contain a poisonous substance.

  • August 14, 2007

    AstraZeneca Fires Back At Plaintiffs In FLSA Suits

    AstraZeneca LP has responded to the plaintiffs in two putative class action wage-and-hour lawsuits that accuse the pharmaceutical company of misclassifying its sales representatives as exempt from federally mandated overtime pay requirements.